Spermatogenesis improved by suppressing the high level of endogenous gonadotropins in idiopathic non-obstructive azoospermia: a case control pilot study
Xuechun Hu, Zheng Ding, Zhiwei Hong, Zhichuan Zou, Yuming Feng, Ruilou Zhu, Jinzhao Ma, Xie Ge, Chaojun Li, Bing Yao, Xuechun Hu, Zheng Ding, Zhiwei Hong, Zhichuan Zou, Yuming Feng, Ruilou Zhu, Jinzhao Ma, Xie Ge, Chaojun Li, Bing Yao
Abstract
Background: Elevated plasma gonadotropins were associated with desensitization of Sertoli and Leydig cells in the male testis. Testis spermatogenesis ability would be improved via inhibiting high endogenous gonadotropin in patients with severe oligozoospermia. Whether it would be beneficial for non-obstructive azoospermia (NOA) patients was still unclear.
Methods: Goserelin, a gonadotropin releasing hormone agonist (GnRHα) was used to suppress endogenous gonadotropin levels (gonadotropin reset) in the NOA patients, improving the sensitization of the Sertoli and Leydig cells. Then human menopausal gonadotropin (hMG) and human chorionic gonadotropin (hCG) were injected to stimulate them to ameliorate the ability of testicular spermatogenesis. The main outcome measure was the existence of spermatozoa in the semen or by testicular sperm extraction (TESE). Elevation of inhibin B and/or ameliorative expression pattern of ZO-1 was the secondary objective.
Results: A total of 35 NOA men who failed to retrieve sperm via TESE were enrolled. Among these, 10 patients without treatment were selected as control group and secondary TESE was performed 6 months later. Of the 25 treated men, inhibin B was elevated in 11 patients in the first 4 weeks (Response group), while only 5 patients had constant increase in the following 20 weeks (Response group 2). Of the 5 men, 2 men acquired sperm (Response group 2B), while 3 failed (Response group 2A). Immunofluorescence of mouse vasa homologue (MVH) and ZO-1 showed that both positive MVH signals and ZO-1 expression were significantly increased in the Response group 2, but only Response group 2B showed ameliorative ZO-1 distribution.
Conclusions: Gonadotropin reset, a new therapeutic protocol with GnRHα, was able to improve the ability of testicular spermatogenesis in the NOA patients through restoring the sensitivity of Sertoli and Leydig cells, which were reflected by elevated inhibin B and ameliorative ZO-1 expression and distribution.
Trial registration: ClinicalTrials.gov identifier: NCT02544191 .
Keywords: GnRHα; Gonadotropin reset; NOA.
Conflict of interest statement
Ethics approval and consent to participateThe study protocol was approved by the Research Ethics Committee of Nanjing Jinling Hospital and informed consent was obtained from all the participants.
Consent for publicationAll authors provided final approval of the version to be published and agree to be accountable for all aspects of the work in ensuring that questions.
Competing interestsThe authors declare that they have no competing interests.
Publisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
- Aziz N. The importance of semen analysis in the context of azoospermia. Clinics (Sao Paulo) 2013;68(Suppl 1):35–38. doi: 10.6061/clinics/2013(Sup01)05.
- Esteves SC, Miyaoka R, Agarwal A. An update on the clinical assessment of the infertile male. [corrected] Clinics (Sao Paulo) 2011;66:691–700. doi: 10.1590/S1807-59322011000400026.
- Esteves SC. Clinical management of infertile men with nonobstructive azoospermia. Asian J Androl. 2015;17:459–470.
- Belva F, De Schrijver F, Tournaye H, Liebaers I, Devroey P, Haentjens P, Bonduelle M. Neonatal outcome of 724 children born after ICSI using non-ejaculated sperm. Hum Reprod. 2011;26:1752–1758. doi: 10.1093/humrep/der121.
- Tsujimura A, Matsumiya K, Miyagawa Y, Tohda A, Miura H, Nishimura K, Koga M, Takeyama M, Fujioka H, Okuyama A. Conventional multiple or microdissection testicular sperm extraction: a comparative study. Hum Reprod. 2002;17:2924–2929. doi: 10.1093/humrep/17.11.2924.
- Shiraishi K, Ishikawa T, Watanabe N, Iwamoto T, Matsuyama H. Salvage hormonal therapy after failed microdissection testicular sperm extraction: a multi-institutional prospective study. Int J Urol. 2016;23:496–500. doi: 10.1111/iju.13076.
- Shiraishi K, Ohmi C, Shimabukuro T, Matsuyama H. Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia. Hum Reprod. 2012;27:331–339. doi: 10.1093/humrep/der404.
- Shinjo E, Shiraishi K, Matsuyama H. The effect of human chorionic gonadotropin-based hormonal therapy on intratesticular testosterone levels and spermatogonial DNA synthesis in men with non-obstructive azoospermia. Andrology. 2013;1:929–935. doi: 10.1111/j.2047-2927.2013.00141.x.
- Kato Y, Shiraishi K, Matsuyama H. Expression of testicular androgen receptor in non-obstructive azoospermia and its change after hormonal therapy. Andrology. 2014;2:734–740. doi: 10.1111/j.2047-2927.2014.00240.x.
- Oka S, Shiraishi K, Matsuyama H. Effects of human chorionic gonadotropin on testicular interstitial tissues in men with non-obstructive azoospermia. Andrology. 2017;5:232–239. doi: 10.1111/andr.12292.
- Foresta C, Bettella A, Spolaore D, Merico M, Rossato M, Ferlin A. Suppression of the high endogenous levels of plasma FSH in infertile men are associated with improved Sertoli cell function as reflected by elevated levels of plasma inhibin B. Hum Reprod. 2004;19:1431–1437. doi: 10.1093/humrep/deh255.
- Heidargholizadeh S., Aydos S. E., Yukselten Y., Ozkavukcu S., Sunguroglu A., Aydos K. A differential cytokine expression profile before and after rFSH treatment in Sertoli cell cultures of men with nonobstructive azoospermia. Andrologia. 2016;49(4):e12647. doi: 10.1111/and.12647.
- Gnanaprakasam MS, Chen CJ, Sutherland JG, Bhalla VK. Receptor depletion and replenishment processes: in vivo regulation of gonadotropin receptors by luteinizing hormone, follicle stimulating hormone and ethanol in rat testis. Biol Reprod. 1979;20:991–1000. doi: 10.1095/biolreprod20.5.991.
- O'Shaughnessy PJ, Brown PS. Reduction in FSH receptors in the rat testis by injection of homologous hormone. Mol Cell Endocrinol. 1978;12:9–15. doi: 10.1016/0303-7207(78)90097-7.
- Themmen AP, Blok LJ, Post M, Baarends WM, Hoogerbrugge JW, Parmentier M, Vassart G, Grootegoed JA. Follitropin receptor down-regulation involves a cAMP-dependent post-transcriptional decrease of receptor mRNA expression. Mol Cell Endocrinol. 1991;78:R7–13. doi: 10.1016/0303-7207(91)90130-K.
- Foresta C, Selice R, Moretti A, Pati MA, Carraro M, Engl B, Garolla A. Gonadotropin administration after gonadotropin-releasing-hormone agonist: a therapeutic option in severe testiculopathies. Fertil Steril. 2009;92:1326–1332. doi: 10.1016/j.fertnstert.2008.07.1766.
- Hayes FJ, Pitteloud N, DeCruz S, Crowley WF, Jr, Boepple PA. Importance of inhibin B in the regulation of FSH secretion in the human male. J Clin Endocrinol Metab. 2001;86:5541–5546. doi: 10.1210/jcem.86.11.8031.
- Iliadou PK, Tsametis C, Kaprara A, Papadimas I, Goulis DG. The Sertoli cell: Novel clinical potentiality. Hormones (Athens) 2015;14:504–514. doi: 10.14310/horm.2002.1648.
- Weinbauer GF, Wessels J. ‘Paracrine’ control of spermatogenesis. Andrologia. 1999;31:249–262. doi: 10.1046/j.1439-0272.1999.00295.x.
- Fink C, Weigel R, Fink L, Wilhelm J, Kliesch S, Zeiler M, Bergmann M, Brehm R. Claudin-11 is over-expressed and dislocated from the blood-testis barrier in Sertoli cells associated with testicular intraepithelial neoplasia in men. Histochem Cell Biol. 2009;131:755–764. doi: 10.1007/s00418-009-0576-2.
- Haverfield JT, Meachem SJ, O'Bryan MK, McLachlan RI, Stanton PG. Claudin-11 and connexin-43 display altered spatial patterns of organization in men with primary seminiferous tubule failure compared with controls. Fertil Steril. 2013;100:658–666. doi: 10.1016/j.fertnstert.2013.04.034.
- Pummi K, Malminen M, Aho H, Karvonen SL, Peltonen J, Peltonen S. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol. 2001;117:1050–1058. doi: 10.1046/j.0022-202x.2001.01493.x.
- World Health Organization . Laboratory manual for the examination and processing of human semen. 5. Geneva: World Health Organization; 2010. pp. 10–56.
- Foresta C, Varotto A, Scandellari C. Assessment of testicular cytology by fine needle aspiration as a diagnostic parameter in the evaluation of the azoospermic subject. Fertil Steril. 1992;57:858–865. doi: 10.1016/S0015-0282(16)54971-1.
- Hu Xuechun, Ge Xie, Liang Wei, Shao Yong, Jing Jun, Wang Cencen, Zeng Rong, Yao Bing. Effects of saturated palmitic acid and omega-3 polyunsaturated fatty acids on Sertoli cell apoptosis. Systems Biology in Reproductive Medicine. 2018;64(5):368–380. doi: 10.1080/19396368.2018.1471554.
- Bai Shun, Cheng Le, Zhang Yingwen, Zhu Chunsen, Zhu Zhiping, Zhu Ruping, Cheng C Yan, Ye Lan, Zheng Ke. A germline-specific role for the mTORC2 component Rictor in maintaining spermatogonial differentiation and intercellular adhesion in mouse testis. MHR: Basic science of reproductive medicine. 2018;24(5):244–259.
- Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men. J Urol. 2001;165:837–841. doi: 10.1016/S0022-5347(05)66540-8.
- Reifsnyder JE, Ramasamy R, Husseini J, Schlegel PN. Role of optimizing testosterone before microdissection testicular sperm extraction in men with nonobstructive azoospermia. J Urol. 2012;188:532–536. doi: 10.1016/j.juro.2012.04.002.
- Shiraishi K, Matsuyama H. Gonadotoropin actions on spermatogenesis and hormonal therapies for spermatogenic disorders [review] Endocr J. 2017;64:123–131. doi: 10.1507/endocrj.EJ17-0001.
- Regueira M, Artagaveytia SL, Galardo MN, Pellizzari EH, Cigorraga SB, Meroni SB, Riera MF. Novel molecular mechanisms involved in hormonal regulation of lactate production in Sertoli cells. Reproduction. 2015;150:311–321. doi: 10.1530/REP-15-0093.
- de Kretser DM, Loveland KL, Meinhardt A, Simorangkir D, Wreford N. Spermatogenesis. Hum Reprod. 1998;13(Suppl 1):1–8. doi: 10.1093/humrep/13.suppl_1.1.
- Pakarainen T, Zhang FP, Makela S, Poutanen M, Huhtaniemi I. Testosterone replacement therapy induces spermatogenesis and partially restores fertility in luteinizing hormone receptor knockout mice. Endocrinology. 2005;146:596–606. doi: 10.1210/en.2004-0913.
- Conti M, Toscano MV, Petrelli L, Geremia R, Stefanini M. Involvement of phosphodiesterase in the refractoriness of the Sertoli cell. Endocrinology. 1983;113:1845–1853. doi: 10.1210/endo-113-5-1845.
- Sanchez-Yague J, Hipkin RW, Ascoli M. Biochemical properties of the agonist-induced desensitization of the follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin-responsive adenylyl cyclase in cells expressing the recombinant gonadotropin receptors. Endocrinology. 1993;132:1007–1016. doi: 10.1210/endo.132.3.8440169.
- Fletcher PW, Reichert LE., Jr Cellular processing of follicle-stimulating hormone by Sertoli cells in serum-free culture. Mol Cell Endocrinol. 1984;34:39–49. doi: 10.1016/0303-7207(84)90157-6.
- Allenby G, Foster PM, Sharpe RM. Evidence that secretion of immunoactive inhibin by seminiferous tubules from the adult rat testis is regulated by specific germ cell types: correlation between in vivo and in vitro studies. Endocrinology. 1991;128:467–476. doi: 10.1210/endo-128-1-467.
- Levi M, Hasky N, Stemmer SM, Shalgi R, Ben-Aharon I. Anti-Mullerian hormone is a marker for chemotherapy-induced testicular toxicity. Endocrinology. 2015;156:3818–3827. doi: 10.1210/en.2015-1310.
- Liu Z, Mao J, Wu X, Xu H, Wang X, Huang B, Zheng J, Nie M, Zhang H. Efficacy and outcome predictors of gonadotropin treatment for male congenital hypogonadotropic hypogonadism: a retrospective study of 223 patients. Medicine (Baltimore) 2016;95:e2867. doi: 10.1097/MD.0000000000002867.
- Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998;141:1539–1550. doi: 10.1083/jcb.141.7.1539.
- Byers S, Graham R, Dai HN, Hoxter B. Development of Sertoli cell junctional specializations and the distribution of the tight-junction-associated protein ZO-1 in the mouse testis. Am J Anat. 1991;191:35–47. doi: 10.1002/aja.1001910104.
- McLachlan RI, Rajpert-De Meyts E, Hoei-Hansen CE, de Kretser DM, Skakkebaek NE. Histological evaluation of the human testis--approaches to optimizing the clinical value of the assessment: mini review. Hum Reprod. 2007;22:2–16. doi: 10.1093/humrep/del279.
Source: PubMed